PVAC And Partners Advance In Ensuring Nigerians Access Affordable Malaria Diagnostics And Medicines
Abuja, Nigeria, February 26, 2026
The (PVAC), in collaboration with partners in the (NMEP), has announced significant progress under the Affordable Diagnostics and Medicines for Malaria (ADMFM) initiative. The technical team driving the project says it is making steady strides toward ensuring Nigerians have access to affordable, quality malaria treatment and essential commodities.
Speaking during the ADMFM Technical Working Group meeting to align on next steps, PVAC National Coordinator, Dr. Abdu Mukhtar, underscored the critical importance of malaria as a major public health priority in Nigeria. He highlighted the urgent need to strengthen the supply of essential medicines and diagnostic commodities to effectively combat the disease.
Dr. Mukhtar noted that malaria elimination remains a key agenda of the current administration of , under the leadership of the Coordinating Minister of Health and Social Welfare, . According to him, the administration is committed to building a resilient healthcare system capable of delivering affordable and accessible malaria interventions to all Nigerians.
He emphasized, however, that the government cannot achieve these ambitious goals alone.
Strong collaboration with multiple stakeholders—including development partners, private sector actors, and local manufacturers—is essential. Dr. Mukhtar stressed that sustainable access to malaria treatment and diagnostics can only be achieved through strategic partnerships across the healthcare value chain, particularly by supporting local production to reduce dependence on imports and enhance affordability.
Also speaking at the meeting, the National Coordinator of NMEP, Dr. Nnenna Ogbulafor, commended members of the technical working group for their dedication and contributions. She highlighted the project’s importance to vulnerable populations, especially young children and pregnant women, who bear a disproportionate burden of malaria-related illness and mortality.
Dr. Ogbulafor noted that collaboration with local manufacturers represents a key strategic approach to ensuring sustainable access to high-quality malaria treatment and diagnostic tools. By strengthening local capacity, Nigeria can enhance supply chain resilience, reduce stockouts, and improve timely access to life-saving commodities.
The ADMFM initiative forms a critical component of efforts to strengthen Nigeria’s healthcare value chain, improve health outcomes, and accelerate progress toward the national goal of malaria elimination. Through coordinated action, strategic partnerships, and sustained commitment, PVAC and its partners aim to make affordable malaria diagnostics and medicines a reality for millions of Nigerians.
